Dr. Reddy's Laboratories
148 hedge funds and large institutions have $862M invested in Dr. Reddy's Laboratories in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 47 reducing their positions, and 19 closing their positions.
33% more call options, than puts
Call options by funds: $484K | Put options by funds: $363K
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
0% more funds holding
Funds holding: 148 → 148 (0)
0% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 47
0.32% less ownership
Funds ownership: 64.56% → 64.24% (-0.32%)
1% less capital invested
Capital invested by funds: $870M → $862M (-$8.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$12.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$12.1M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$12M |
| 4 |
Renaissance Technologies
New York
|
+$11.9M |
| 5 |
RG
Renaissance Group
Covington,
Kentucky
|
+$9.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$23.5M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$14.5M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.26M |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$8.14M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.17M |
RDY Hedge Fund Activity: Q1 2020 in Review
148 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2020, worth a combined $862M — down 0.95% from $870M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new RDY positions and 19 closed out — a net gain of 3 holders — while 47 added to existing stakes and 47 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $12.8M. The largest seller was BlackRock, cutting an estimated $23.5M.
- 148 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $862M of Dr. Reddy's Laboratories stock for Q1 2020, down 0.95% quarter-over-quarter.
- 22 funds opened new Dr. Reddy's Laboratories positions in Q1 2020 and 19 closed out, a net change of +3 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2020 was Goldman Sachs, an estimated $12.8M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2020 was BlackRock, an estimated $23.5M sold.
Based on aggregated 13F filings for Q1 2020.